Navigation Links
Jefferson researchers uncover new evidence of prolactin's possible role in breast cancer
Date:9/28/2007

(PHILADELPHIA) Scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered new molecular evidence of the role of the hormone prolactin in breast cancer. They have found that prolactin, a pituitary hormone that normally stimulates breast development and milk production, initiates a new signaling pathway that may regulate the growth and survival of breast cancer cells.

The work, which appears this month in the journal Molecular Endocrinology, identifies the protein Jak1 as playing a key part in prolactin signaling in breast cancer. Jak1, which belongs to the cell growth-promoting tyrosine kinase class of enzymes, could represent a new drug target for treating breast cancer.

In breast cancer cells, we found that Jak1 not only stimulates conventional prolactin signaling via proteins such as Stat5, but also that Jak1 recruited new signals, especially Stat3 and ERK, says Hallgeir Rui, M.D., Ph.D., professor of Cancer Biology at Jefferson Medical College of Thomas Jefferson University and principal investigator of the study. Because Stat3 and ERK typically are considered tumor-promoting, inhibitors of Jak1 may become useful in breast cancer treatment.

Receptors for prolactin, have previously been shown to promote breast cancer cell growth, survival, and differentiation, Dr. Rui explains, through signaling pathways that involve activation of such proteins as Stat5, ERK, and Akt. Prolactin is also known toactivate Stat3, which has been implicated as an oncogene involved in cancer cell growth and survival. In the current study, when Jak1 protein expression was experimentally disrupted in breast cancer cells, prolactin signaling through Stat3 and ERK was completely blocked. Signaling through Stat5 and Akt was reduced but still present.

Until now, prolactin was believed to signal only through Jak2 to mediate its effects, says Lynn Neilson, Ph.D., a postdoctoral fellow in the Department of Cancer Biology at
'/>"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Jefferson Physicians Report on Potentially Fatal Complication of Heart Attack
2. Jefferson Researchers Want to Learn If Heart Defect at Heart of Some Migraines
3. Researchers urge caution in using ear tube surgery
4. Researchers Scale to assess the Severity of Epilepsy in Kids
5. Researchers identify the early makers of Neonatal Sepsis
6. OHSU Researchers Announce New Discovery
7. Researchers Identify Gene Connected To Bipolar Disorder
8. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
9. Researchers trick Alzheimers Enzyme
10. Researchers find new HIV hiding place
11. Gene researchers make Malaria-resistant mosquito
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Aflac Incorporated announced today that it has ... notes with a coupon of 6.9%. The notes ... to yield 6.984%. The company anticipates using the ... general corporate purposes. ,, Commenting on the pricing ... Chief Financial Officer Kriss Cloninger III commented: "This ...
(Date:12/14/2009)... Calif., Dec. 14 Tough Enough To Wear ... breast cancer, celebrated its fifth anniversary at the ... the Wrangler National Finals Rodeo (Wrangler NFR) in ... with rough-and-tumble rodeo cowboys, the support of the ... the sold-out crowd sported pink shirts, hats, bracelets ...
(Date:12/14/2009)... in Canada for 13 years under government controlled health care, before ... economy. In speaking engagements and in his new book, Health Reform: ... fragility of such a system and its threat to real health ... ... Lee Kurisko , a diagnostic radiologist from Minnesota, warns Americans not ...
(Date:12/14/2009)... -- Skilled nursing facilities (SNFs) in Ohio are making ... deal with a 92 percent increase in the state-imposed ... $12.01 per bed per day, scheduled for December 15. ... pay an additional $17,520 to the state each month, ... $438,365 yearly. ,, Nearly 96 percent of skilled nursing ...
(Date:12/14/2009)... -- Grubb & Ellis Healthcare REIT II, Inc. announced today ... to stockholders of record as of the close of business ... 2010 and ending on Feb. 28, 2010. The distributions ... year and will be equal to an annualized distribution rate ... share. These distributions will be aggregated and paid in ...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3
... Canadian Regulatory Authorities Approve 3f(R) Aortic Bioprosthesis for Sale ... ... Company Updates Financial Outlook for 2008, MINNEAPOLIS, Jan. 31 ... products and services, today announced it has received a request,for additional information and ...
... Patients treated at top-rated hospitals nationwide are nearly ... those admitted to all other hospitals, according to ... independent healthcare ratings organization. Patients who undergo surgery ... five percent lower risk of complications during their ...
... autoimmune disease, tend to die younger and, largely ... this increasingly recognized fact is that inflammation promotes ... the C-reactive protein (CRP) level has been shown ... However, other highly inflammatory diseasesCrohns, for exampledo not ...
... New Information Strengthens Community,s Demand to Save St. ... ... Health told the San,Francisco Chronicle in a January 27 article the reason ... Luke,s,Hospital, the South of Market facility they are trying to close:, ...
... Give Kids A Smile! events, CHICAGO, Jan. ... and on Feb. 1, more than 51,000 dental ... 500,000 children from low-income,families, at more than 2,000 ... Association,s (ADA) sixth annual Give Kids A Smile ...
... Will Emcee Event ... New York City, NEW YORK, Jan. 30 Woman,s Day ... by honoring four women who,have made significant contributions to the fight ... Insider,s Lara Spencer will emcee the event on Thursday, January,31st at ...
Other Medicine News:Health News:ATS Medical Provides Update on First Generation Tissue Valve Approval 2Health News:ATS Medical Provides Update on First Generation Tissue Valve Approval 3Health News:Top hospitals have 27 percent lower mortality, annual HealthGrades study finds 2Health News:Top hospitals have 27 percent lower mortality, annual HealthGrades study finds 3Health News:The HLA-DRB1 gene and premature death in rheumatoid arthritis 2Health News:The HLA-DRB1 gene and premature death in rheumatoid arthritis 3Health News:Open Wide! Nation's Dentists Address Access With Free Care for Kids 2Health News:Open Wide! Nation's Dentists Address Access With Free Care for Kids 3Health News:Woman's Day Presents the 5th Annual 'Red Dress Awards' Honoring Women Who Are Leaders in the Fight Against Heart Disease 2Health News:Woman's Day Presents the 5th Annual 'Red Dress Awards' Honoring Women Who Are Leaders in the Fight Against Heart Disease 3Health News:Woman's Day Presents the 5th Annual 'Red Dress Awards' Honoring Women Who Are Leaders in the Fight Against Heart Disease 4
(Date:12/14/2009)... 14 Transcept Pharmaceuticals, Inc. (Nasdaq: ... a Notice of Allowance from the United States ... U.S. patent application no. 11/060,641, which covers the ... tartrate sublingual tablet), the lead Transcept product candidate. ... earlier than February 2025. ,, "This is the ...
(Date:12/14/2009)... Dec. 14 In response to an ... 2009, in which the Agency recommended that healthcare ... (SS1) sterile processing system, hospitals throughout the U.S. ... alternatives to that product. According to the FDA, ... SS1 that may affect the safety or the ...
(Date:12/14/2009)... directors of Eli Lilly and Company (NYSE: ... quarter of 2010 of $0.49 a share on outstanding ... March 10, 2010 to shareholders of record at the ... ,, Lilly, a leading innovation-driven corporation, is developing a ... research from its own worldwide laboratories and from collaborations ...
Breaking Medicine Technology:Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 2Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 3Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 4ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 2ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 3New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 1New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 2New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 3New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 4SourceMedical Earns Cardinal Health Innovation Award 61207 1SourceMedical Earns Cardinal Health Innovation Award 61207 2The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 1The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 2The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 3The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 4The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 5The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 6The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 7
... for 4Q07/1Q08, DALLAS, Aug. 20 Access ... update on the clinical,development plan of ProLindac, its ... additional human clinical trials to be initiated in,late ... recurrent ovarian,cancer patients, designed to optimize single agent ...
... 17 AutoGenomics, a leader in,developing automated molecular ... that it submitted to the FDA for 510(k) ... the Harvard Medical,School-Partners HealthCare Center for Genetics and ... a drug prescribed to help prevent,blood clots. With ...
Other Medicine Technology:Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 2Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 3Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 4Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity 2
... The Plan-Neofluar 63x/1.25 Oil Ph3 ... reflected-light reflection contrast. This method ... brightfield microscopy, such as cells ... a Petri dish. Moreover, this ...
... high-power, apochromatically corrected objectives ... the most exacting demands ... are suitable for visual ... 25 mm and feature ...
... redesigned by Nikon allowing the contrast direction ... the objective. That direction, once set, is ... 10x to 40x.,Apodized phase contrast objectives,Nikon's Apodized ... image by reducing internal reflections. The result ...
... Featuring an extra-high transmission rate, especially ... comparable to the CFI plan Achromat ... fluorescence observation and photomicrography. Because ... function as multipurpose objectives for brightfield, ...
Medicine Products: